Skip to main content

Table 2 Univariate analysis of the association of SVR with patients characteristics

From: HCV infected prisoners: should they be still considered a difficult to treat population?

 

SVR

No SVR

Tot

OR

95% CI

p

N

%

N

%

Age (years)

         
 

40+

7

33.3

14

66.7

21

1

  

<40

18

62.1

11

37.9

29

3.27

1.01-10.62

0.048

BMI (kg/m2)

         
 

<25

10

41.7

14

58.3

24

1

  

25+

15

57.7

11

42.3

26

1.91

0.62-5.88

0.260

IVDUs

         
 

Yes

16

47.1

18

52.9

34

1

  

No

9

56.3

7

43.8

16

1.45

0.44-4.78

0.545

Biopsy staging (Metavir)

        
 

F3-F4

2

15.4

11

84.6

13

1

  

F1-F2

23

62.6

14

37.8

37

9.04

1.74-46.89

0.009

ALT (mU/mL)

         
 

60+

18

45.0

22

55.0

40

1

  

<60

7

70.0

3

30.0

10

2.85

0.-64-12.64

0.168

HCV genotype

         
 

1

8

32.0

17

68.0

25

1

  

Not 1

17

68.0

8

32.0

25

4.52

1.38-14.82

0.013

aHCV viral load (IU/ml)

        
 

High

13

40.6

19

59.4

32

1

  

Low

12

66.7

6

33.3

18

2.92

0.87-9.78

0.082

  1. acategorized in High (≥6×105 IU/ml) and Low (<6×105 IU/ml).
  2. BMI Body Mass Index, IVDUs Intravenous drug users, SVR Sustained Virologic Response, OR Odds Ratio, CI Confidence Interval.